IP Library Granted Patent US 11,667,886
Granted Patent B2
US 11,667,886 · App. 16/621,572 · Granted Jun 6, 2023

Recombinant yeast cell

Inventors: Ioannis Papapetridis (Delft, NL); Jacobus Thomas Pronk (Delft, NL)
Assignee: DSM IP ASSETS B.V.
C12N1/16C12N1/185C12N15/52C12P7/10C12P2203/00C12R2001/865C12Y101/01008C12Y202/01001C12Y202/01002C12Y207/01019C12Y401/01039C12Y501/03001C12Y503/01006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,667,886
App. No.
16/621,572
Granted
Jun 6, 2023
Kind
B2
Abstract

The present invention describes a recombinant yeast cell functionally expressing one or more heterologous nucleic acid sequences encoding for ribulose-1,5-phosphate carboxylase/oxygenase (EC4.1.1.39; Rubisco), and optionally one or more molecular chaperones for Rubisco, and one or more phosphoribulokinase (EC2.7.1.19; PRK), wherein one or more genes of the non-oxidative branch of the pentose phosphate pathway are overexpressed and/or wherein said yeast cell comprises a deletion or disruption of a glycerol-3-phosphate dehydrogenase (GPD) gene.

Claims (20)

1. A recombinant yeast cell functionally expressing one or more heterologous nucleic acid sequences encoding for ribulose-1,5-phosphate carboxylase/oxygenase (Rubisco) having EC number 4.1.1.39 and further comprising one or more phosphoribulokinase (PRK) having EC number 2.7.1.19, wherein:

one or more genes of the non-oxidative branch of the pentose phosphate pathway, and encoding an enzyme selected from the group consisting of transaldolase having EC number 2.2.1.2, transketolase having EC number 2.2.1.1, ribose-5-phosphate isomerase having EC number 5.3.1.6 and D-ribulose-5-phosphate 3-epimerase having EC number 5.1.3.1, are overexpressed;

the PRK is under control of a promoter which has a PRK expression ratio anaerobic/aerobic of 2 or more; and

the Rubisco and the one or more genes of the non-oxidative branch of the pentose phosphate pathway are under control of one or more constitutive promoters, and

the recombinant yeast cell further comprising a deletion or disruption of a glycerol-3-phosphate dehydrogenase (GPD) gene.

2. The recombinant yeast cell according to claim 1 wherein the GPD gene encodes for an enzyme having EC number 1.1.1.8.

3. The recombinant yeast cell according to claim 1 wherein the GPD gene comprises GPD1 and GPD2, and wherein the GPD1 and GPD2 are deleted or disrupted.

4. The recombinant yeast cell according to claim 1 , wherein the one or more genes of the pentose phosphate pathway is selected from the group consisting of TAL1, TAL2, NQM1, TKL1, TKL2, RPE1, RKI1, or a combination thereof.

5. The recombinant yeast cell according to claim 1 wherein the yeast cell is selected from the group of Saccharomycetaceae.

6. A process for preparing an organic compound comprising culturing the recombinant yeast cell according to claim 1 with a carbon source, thereby forming the organic compound.

7. The process according to claim 6 wherein the carbon source is a starch hydrolysate.

8. The process according to claim 6 wherein the carbon source is a corn fiber hydrolysate.

9. The process according to claim 6 wherein the carbon source is a corn stover hydrolysate.

10. The recombinant yeast cell according to claim 1 , wherein the one or more genes of the pentose phosphate pathway comprise RPE1, TKL1, TAL1, TAL2, RKI1, and NQM1.

11. The recombinant yeast cell according to claim 10 , functionally expressing one or more heterologous nucleic acid sequences encoding one or more molecular chaperones for Rubisco.

12. The recombinant yeast cell according to claim 11 , wherein the molecular chaperones for Rubisco are groES and groEL.

13. The recombinant yeast cell according to claim 1 , wherein the promoter which has a PRK expression ratio anaerobic/aerobic of 2 or more is selected from the group consisting of FET4 (FErrous Transport: YMR319C), YHK8 (YHR048W), AAC3 (ADP/ATP Carrier: YBR085W), DIP5 (DIcarboxylic amino acid Permease; YPL265W), HEM13 (HEMe biosynthesis; YDR044W), YNR014W, YAR028W, FUN57, OYE2 (Old Yellow Enzyme; YHR179W), SUR2 (SUppressor of Rvs161 and rvs167 mutations; YDR297W), FRDS1 (Fumarate ReDuctase; YEL047C), PIS1 (Phosphatidyl Inositol Synthase; YPR113W), LAC1 (Longevity-Assurance gene Cognate (LAG1 Cognate); YKL008C), YGR035C, YAL028W, EUG1 (ER protein Unnecessary for Growth; YDR518W), HEM14 (HEMe biosynthesis; YER014W), ISU2 (IscU homolog; YOR226C), ERG26 (ERGosterol biosynthesis; YGL001C), YMR252C, SML1 (Suppressor of Mec Lethality; YML058W), PAU7 (YAR020C), PAU5 (YFL020C), YLL064C, YGR294W, YIL176C, YGL261C, YOL161C, PAU1 (YJL223C), PAU6 (YNR076W), YDR542W, YIR041W, YKL224C, PAU3 (YCR104W), YLL025W, YOR394W, YHL046C, YMR325W, YAL068C, YPL282C, PAU2 (YEL049W), and PAU4 (YLR461W).

14. The recombinant yeast cell according to claim 1 , functionally expressing one or more heterologous nucleic acid sequences encoding one or more molecular chaperones for Rubisco, wherein the molecular chaperones for Rubisco are groES and groEL, wherein the promoter which has a PRK expression ratio anaerobic/aerobic of 2 or more is DAN1 (Delayed ANaerobic; YJR150C), and wherein the one or more genes of the pentose phosphate pathway comprise RPE1, TKL1, TAL1, TAL2, RKI1, and NQM1.

15. The process according to claim 6 wherein the organic compound is an alcohol.

16. The process according to claim 6 wherein the carbon source is a carbohydrate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2023
From: DSM IP ASSETS B.V.
To: DANISCO US INC.
Reel/Frame 066005/0848 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICANT NAME PREVIOUSLY RECORDED AT REEL: 051255 FRAME: 0085. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 30, 2020
From: PAPAPETRIDIS, IOANNIS; PRONK, JACOBUS THOMAS
To: DSM IP ASSETS B.V.
Reel/Frame 051756/0036 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2019
From: PAPAPETRIDIS, IOANNIS; PRONK, JACOBUS THOMAS
To: DSM INTELLECTUAL PROPERTY B.V.
Reel/Frame 051255/0085 →
Priority Claims (3)
EP 17175637 · Jun 13, 2017 · regional
EP 17204602 · Nov 30, 2017 · regional
EP 18153828 · Jan 29, 2018 · regional
Continuity (1)
Related Publication 20200157489A1 · May 21, 2020
Cited By (1)
US 12,398,398